All Press Releases for February 18, 2021

2021 Kidney Disease Impact Conference

The Impact of COVID-19 on Diabetes, Dialysis and Kidney Disease

    LOS ANGELES, CA, February 18, 2021 /24-7PressRelease/ --

Kidneys Quest Foundation

2021 Kidney Disease Impact Conference

Tuesday, March 9, 2021 from 8:00 am to 1:15 pm (Pacific Time in the U.S.)

The event will be streaming as a virtual international healthcare conference, a full day series of informative webinars.

2021 THEME:
The Impact of COVID-19 on Diabetes, Dialysis and Kidney Disease

The pandemic has severely impacted our lives, our healthcare systems, hospitals, medical facilities and healthcare professionals. How does this affect surgeries and transplants? What new or additional precautions and procedures are necessary for dialysis, blood transfusions and blood draws? How has COVID-19 affected diabetes and kidney disease patients, dialysis centers, treatment and medical procedures? This conference will focus on updates, recent information, clinical breakthroughs and healthcare issues, by bringing greater awareness about Diabetic Kidney Disease (DKD) during and after COVID-19.

A dynamic day of keynote speakers that include medical professionals and kidney disease transplant specialists from the top three Kidney Transplant Organizations in the U.S., educational workshops, resources available plus information and support sources from people and companies who understand the needs of diabetic and renal patients.

Rebecca Craig-Schapiro, MD PhD, New York Presbyterian and Well Cornell Medical Center / LaTonya J. Hickson, MD, Mayo Clinic / Jose Manuel Monroy -Trujillo, MD, Johns Hopkins Hospital / Aamer H Jamali MD FACC, FSCAI Interventional Cardiology Medical Group / Zahi Nassoura MD FACS, San Fernando Valley Vascular Group / Mavis Williams Billips, MD MPH, City of Angels Dermatology inc. / Tom Mone, CEO, One Legacy / Nina Abiera, LCSW MPA NSW-C / Shelly Greve, RN BSN

FAQs on Kidney Transplantation in the Era of COVID-19 / The Potential of Cell-Based Regenerative Therapy for Diabetic Kidney Disease / SGLT2 inhibitors and their use in diabetic nephropathy / Vascular Disease and Its Effects on Diabetic Kidney Disease / Cardiovascular Disease Associated with DKD / Dermatological Lesions in Kidney Transplant Patients / Health Department Updates on Chronic Diseases and COVID-19

or on the Kidneys Quest Foundation website at

Carolyn Lemos-Urquidez, President, Kidneys Quest Foundation • phone: (818) 521 6348 or email: [email protected] • website:

# # #

Contact Information

Carolyn Lemos- Urquidez
Kidneys Quest Foundation Inc
United States
Voice: 818-521-6348
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: